Colorcon Expands Manufacturing and Completes Renovation of North America Campus

Harleysville, PA, 19th December 2019. Colorcon, Inc., a leading global excipient company announces the completion of a major expansion and renovation at its North America production facility in West Point, Pennsylvania. The multimillion-dollar investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products throughout the US, Canada, Puerto Rico, Mexico, Colombia, Peru, Bolivia as well as the northern areas of Central and Latin America. 

Simon Tasker, President Americas region explains: “The investment in our West Point, USA facility brings together expanded material warehousing and new best-in-class quality control laboratories to the existing production capabilities. This supports our future growth expectations, improves our environmental foot print and reduces supply lead times for our customers.” 

Colorcon’s investment sees the consolidation of multiple legacy buildings into one, unified, manufacturing campus which will eliminate the need for off-site warehousing. The merging of these facilities will provide customers with the highest level of traceability on raw materials and finished goods produced at the site. There are also environmental benefits through the reduced transportation of materials between sites, diminishing traffic and noise in the area that surrounds the Colorcon property. 

Martti Hedman, Colorcon CEO adds: “Colorcon’s West Point, Pennsylvania, site is one of seven film coating manufacturing sites strategically located around the world and is an important component in Colorcon’s Business Continuity Plan. This multi-year investment helps Colorcon to further improve its service to the customers and is a good example of how Colorcon invests in new capacity ahead of demand.” 

About Colorcon 
Colorcon is a world leader in the development, supply and technical support of specialty excipients: formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industry. Our best-in- class products and technologies are complemented by our extensive application expertise and value-added services to support solid oral dose design, development and manufacture. Our focus on market issues, innovation and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon currently has 11 manufacturing facilities (including seven film coating sites), 21 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.

For more information, visit www.colorcon.com

Colorcon Communications Contact:
Katie Scharff
Director - Global Market Communications
katie.scharff@colorcon.com